Cannell & Co’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Cannell & Co’s Portfolio AWH Stock Details AWH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,413	Closed	-$40.7K	–	278
2023 Q1	$40.7K	Hold	7,413	–	–	﹤0.01%	262
2022 Q4	$37K	Hold	7,413	–	–	﹤0.01%	253
2022 Q3	$41K	Hold	7,413	–	–	﹤0.01%	255
2022 Q2	$65K	Hold	7,413	–	–	﹤0.01%	263
2022 Q1	$116K	Hold	7,413	–	–	﹤0.01%	271
2021 Q4	$197K	Sell	7,413 -400	-5%	-$15.2K	0.01%	273
2021 Q3	$381K	Hold	7,813	–	–	0.01%	242
2021 Q2	$659K	Hold	7,813	–	–	0.02%	205
2021 Q1	$791K	Hold	7,813	–	–	0.02%	194
2020 Q4	$786K	Hold	7,813	–	–	0.03%	182
2020 Q3	$362K	Hold	7,813	–	–	0.01%	201
2020 Q2	$450K	Buy	+7,813	New	+$522K	0.02%	178

Other funds holding AWH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QPW

Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

M&T Bank Buffalo, New York $34.1B AUM 29.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cannell & Co's AWH Position: Q2 2023 in Review

Cannell & Co sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2023, closing a stake of 7,413 shares — an estimated $40.7K sold.

Cannell & Co first reported a position in AWH in Q2 2020 and held it in 12 quarters. The position peaked at $791K in Q1 2021. 22 funds tracked by Wall St. Rank hold AWH as of Q2 2023.

Cannell & Co reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Cannell & Co sold 7,413 Aspira Women's Health Inc. Common Stock shares in Q2 2023, an estimated $40.7K.
Cannell & Co first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 12 quarters.
Cannell & Co's Aspira Women's Health Inc. Common Stock position peaked at $791K in Q1 2021.
22 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2023.

Based on Cannell & Co's 13F filing for Q2 2023, filed 9 Aug 2023.